Joe Biden's chance to prove he runs something - Episode 22 - Hour 1
The Todd Herman Show
English - December 29, 2021 13:00 - 46 minutes - 43.1 MB - ★★★★★ - 1.5K ratingsNews Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
THE THESIS: We can see who is NOT running things and who IS running them by the words of the figurehead vs the actions of the people who allegedly work for him.
THE SCRIPTURE:
32 The king will use deceit to win followers from those who are unfaithful to God, but those who remain faithful will do everything possible to oppose him.
33 Wise leaders will instruct many of the people. But for a while, some of these leaders will either be killed with swords or burned alive, or else robbed of their possessions and thrown into prison. 34 They will receive only a little help in their time of trouble, and many of their followers will be treacherous.
THE NEWS:
Figurehead’s Chief of Stuff, Ron Klain, had some interesting things to say about federal power
[AUDIO] - Figurehead: “No federal solution . . . “
[AUDIO] - Rand Paul on the Fauxch’s bias toward so called “vaccines …”
So … WHY is the FDA still picking winners and losers right along with the rest of The Party?
WAPO will run this, from an academic, but the did the Propaganda of Silence against Kulldorff, Great Barrington, Frontline Docs, Zrenco, Malone, et al . . . → American Association of Physicians and Surgeons: “Molnupiravir’s low efficacy may come as no surprise, because drugs that only mutate a viral genome have never been tested before in people."
On Thursday, the Food and Drug Administration made what may be the most momentous drug-approval decision in its history: It granted emergency-use authorization for Merck’s molnupiravir to treat covid-19. This approval is significant not because molnupiravir is an especially good drug, but because it is a rather ineffective and dangerous one. In particular, molnupiravir might create new variants of SARS-CoV-2 that evade immunity and prolong the pandemic.
The problem with molnupiravir lies in its mechanism of action. Unlike any previous antiviral drug, molnupiravir does only one thing: It introduces mutations into the viral genome. We are already familiar with the fact that viruses naturally mutate to evade immunity; the many mutations of the spike protein in omicron, for example, allow it to evade the antibodies created by prior infections or vaccines. Molnupiravir relies on inducing even more mutations so that eventually the virus’s proteins are damaged beyond function. That molnupiravir can mutate SARS-CoV-2 to death has been demonstrated in the controlled conditions of a petri dish and lab animal cages, leading Merck to test it in covid-19 patients in clinical trials.
Michael Z. Lin is a medical doctor and an associate professor of bioengineering and neurobiology at Stanford University. He conducts research on RNA viruses, including the development of antiviral drugs for covid-19.
New study from Israel: "A total of 247, 65 and 32 children were hospitalised with influenza, COVID-19 and measles respectively. Complication rates were higher following measles than after influenza and SARS-CoV-2 infections.” . . . Hospitalisation rates and direct medical burdens of measles and influenza were significantly higher than those of COVID-19 infection in children." - ACTA PEDIACTRICA
THE MONOLOGUE: QUESTIONS FOR THE PEOPLE WHO RUN JOE BIDEN … ARE YOU GOING TO CALL OFF YOUR PHARMAGANDISTS, NOW?
Here’s what Gupta said BEFORE he started getting paid HUGE money to say the opposite … was THAT why he changed the words that leave his mouth? https://m.youtube.com/watch?v=tbidNLumfJQ&feature=share&fbclid=IwAR1rqiw-bptN7h40e80nNt5eXlWT7iaKwAmv0c_74t0QIWiH19BpA1BiQxo
See omnystudio.com/listener for privacy information.